CTAS vs ZTS · P/E 51, rev $11.26B vs P/E 25, rev $2.47B
Cintas Corporation (CTAS) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the CTAS and ZTS stock pages for the full models.
Not investment advice.